• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

癌症研究中的新兴技术:迈向基于微流控平台和 3D 肿瘤模型的个性化医疗。

Emerging Technologies for Cancer Research: Towards Personalized Medicine with Microfluidic Platforms and 3D Tumor Models.

机构信息

Department of Medicine, University of Udine, Udine, Italy.

Immunopathology and Cancer Biomarkers, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Italy.

出版信息

Curr Med Chem. 2018;25(35):4616-4637. doi: 10.2174/0929867325666180605122633.

DOI:10.2174/0929867325666180605122633
PMID:29874987
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6302350/
Abstract

In the present review, we describe three hot topics in cancer research such as circulating tumor cells, exosomes, and 3D environment models. The first section is dedicated to microfluidic platforms for detecting circulating tumor cells, including both affinity-based methods that take advantage of antibodies and aptamers, and "label-free" approaches, exploiting cancer cells physical features and, more recently, abnormal cancer metabolism. In the second section, we briefly describe the biology of exosomes and their role in cancer, as well as conventional techniques for their isolation and innovative microfluidic platforms. In the third section, the importance of tumor microenvironment is highlighted, along with techniques for modeling it in vitro. Finally, we discuss limitations of two-dimensional monolayer methods and describe advantages and disadvantages of different three-dimensional tumor systems for cell-cell interaction analysis and their potential applications in cancer management.

摘要

在本次综述中,我们描述了癌症研究中的三个热门主题,如循环肿瘤细胞、外泌体和 3D 环境模型。第一部分专门介绍了用于检测循环肿瘤细胞的微流控平台,包括利用抗体和适体的基于亲和力的方法,以及“无标记”方法,利用癌细胞的物理特征,以及最近的异常癌症代谢。在第二部分中,我们简要描述了外泌体的生物学及其在癌症中的作用,以及用于分离它们的常规技术和创新的微流控平台。在第三部分中,强调了肿瘤微环境的重要性,以及体外模拟它的技术。最后,我们讨论了二维单层方法的局限性,并描述了不同的三维肿瘤系统在细胞-细胞相互作用分析中的优缺点及其在癌症管理中的潜在应用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4490/6302350/9c76ac8153f4/CMC-25-4616_F7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4490/6302350/f6470ba21161/CMC-25-4616_F1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4490/6302350/4dc65da970cb/CMC-25-4616_F2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4490/6302350/aa96cdd176ad/CMC-25-4616_F3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4490/6302350/c45d000261b8/CMC-25-4616_F4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4490/6302350/d2ae266382d8/CMC-25-4616_F5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4490/6302350/ba879cb7ff4e/CMC-25-4616_F6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4490/6302350/9c76ac8153f4/CMC-25-4616_F7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4490/6302350/f6470ba21161/CMC-25-4616_F1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4490/6302350/4dc65da970cb/CMC-25-4616_F2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4490/6302350/aa96cdd176ad/CMC-25-4616_F3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4490/6302350/c45d000261b8/CMC-25-4616_F4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4490/6302350/d2ae266382d8/CMC-25-4616_F5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4490/6302350/ba879cb7ff4e/CMC-25-4616_F6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4490/6302350/9c76ac8153f4/CMC-25-4616_F7.jpg

相似文献

1
Emerging Technologies for Cancer Research: Towards Personalized Medicine with Microfluidic Platforms and 3D Tumor Models.癌症研究中的新兴技术:迈向基于微流控平台和 3D 肿瘤模型的个性化医疗。
Curr Med Chem. 2018;25(35):4616-4637. doi: 10.2174/0929867325666180605122633.
2
Shining a Light on Cancer-Photonics in Microfluidic Tumor Modeling and Biosensing.癌症光子学在微流控肿瘤建模和生物传感中的应用研究
Adv Healthc Mater. 2023 Jun;12(14):e2201442. doi: 10.1002/adhm.202201442. Epub 2022 Aug 30.
3
Exosome isolation using nanostructures and microfluidic devices.使用纳米结构和微流控装置进行外泌体分离。
Biomed Mater. 2021 Feb 17;16(2):022005. doi: 10.1088/1748-605X/abde70.
4
Emerging Microfluidic and Biosensor Technologies for Improved Cancer Theranostics.新兴微流控和生物传感器技术在癌症诊断与治疗中的应用
Adv Exp Med Biol. 2022;1379:461-495. doi: 10.1007/978-3-031-04039-9_19.
5
Microfluidic systems for cancer diagnostics.微流控系统在癌症诊断中的应用。
Curr Opin Biotechnol. 2020 Oct;65:37-44. doi: 10.1016/j.copbio.2019.11.022. Epub 2019 Dec 28.
6
Label-Free Isolation of Exosomes Using Microfluidic Technologies.微流控技术的无标记外泌体分离。
ACS Nano. 2021 Nov 23;15(11):17047-17079. doi: 10.1021/acsnano.1c03469. Epub 2021 Nov 1.
7
Liquid Biopsy for Cancer: Circulating Tumor Cells, Circulating Free DNA or Exosomes?癌症的液体活检:循环肿瘤细胞、游离循环DNA还是外泌体?
Cell Physiol Biochem. 2017;41(2):755-768. doi: 10.1159/000458736. Epub 2017 Feb 13.
8
Towards Microfluidic-Based Exosome Isolation and Detection for Tumor Therapy.用于肿瘤治疗的基于微流控的外泌体分离与检测
Nano Today. 2021 Apr;37. doi: 10.1016/j.nantod.2020.101066. Epub 2021 Jan 13.
9
Recent advances in spheroid-based microfluidic models to mimic the tumour microenvironment.基于球体的微流控模型在模拟肿瘤微环境方面的最新进展。
Analyst. 2022 May 17;147(10):2023-2034. doi: 10.1039/d2an00172a.
10
Microengineered 3D Tumor Models for Anti-Cancer Drug Discovery in Female-Related Cancers.用于女性相关癌症抗癌药物发现的微工程化 3D 肿瘤模型。
Ann Biomed Eng. 2021 Aug;49(8):1943-1972. doi: 10.1007/s10439-020-02704-9. Epub 2021 Jan 5.

引用本文的文献

1
Exploring the Complexity of Cutaneous Squamous CellCarcinoma Microenvironment: Focus on Immune Cell Roles by Novel 3D In Vitro Models.探索皮肤鳞状细胞癌微环境的复杂性:通过新型三维体外模型聚焦免疫细胞的作用
Life (Basel). 2025 Jul 23;15(8):1170. doi: 10.3390/life15081170.
2
Breaking the mold: 3D cell cultures reshaping the future of cancer research.打破常规:3D细胞培养重塑癌症研究的未来。
Front Cell Dev Biol. 2024 Nov 26;12:1507388. doi: 10.3389/fcell.2024.1507388. eCollection 2024.
3
Tumor-microenvironment-on-a-chip: the construction and application.

本文引用的文献

1
Toward the Broad Adoption of 3D Tumor Models in the Cancer Drug Pipeline.推动3D肿瘤模型在癌症药物研发流程中的广泛应用。
ACS Biomater Sci Eng. 2015 Oct 12;1(10):877-894. doi: 10.1021/acsbiomaterials.5b00172. Epub 2015 Sep 11.
2
Size-dependent cellular uptake of exosomes.外泌体的大小依赖性细胞摄取。
Nanomedicine. 2017 Apr;13(3):1011-1020. doi: 10.1016/j.nano.2016.12.009. Epub 2016 Dec 18.
3
Dissecting the Heterogeneity of Circulating Tumor Cells in Metastatic Breast Cancer: Going Far Beyond the Needle in the Haystack.
肿瘤微环境芯片:构建与应用。
Cell Commun Signal. 2024 Oct 23;22(1):515. doi: 10.1186/s12964-024-01884-4.
4
pH-sensing hybrid hydrogels for non-invasive metabolism monitoring in tumor spheroids.用于肿瘤球体无创代谢监测的pH传感混合水凝胶
Mater Today Bio. 2023 May 8;20:100655. doi: 10.1016/j.mtbio.2023.100655. eCollection 2023 Jun.
5
3D cancer models: One step closer to human studies.3D 癌症模型:离人体研究更近一步。
Front Immunol. 2023 Apr 11;14:1175503. doi: 10.3389/fimmu.2023.1175503. eCollection 2023.
6
Toward better drug development: Three-dimensional bioprinting in toxicological research.迈向更好的药物研发:毒理学研究中的三维生物打印
Int J Bioprint. 2023 Jan 6;9(2):663. doi: 10.18063/ijb.v9i2.663. eCollection 2023.
7
Recent Advances of Organ-on-a-Chip in Cancer Modeling Research.器官芯片在癌症建模研究中的最新进展。
Biosensors (Basel). 2022 Nov 18;12(11):1045. doi: 10.3390/bios12111045.
8
Microfluidics for the Isolation and Detection of Circulating Tumor Cells.微流控技术用于循环肿瘤细胞的分离和检测。
Adv Exp Med Biol. 2022;1379:389-412. doi: 10.1007/978-3-031-04039-9_16.
9
The Revolutionary Roads to Study Cell-Cell Interactions in 3D In Vitro Pancreatic Cancer Models.在3D体外胰腺癌模型中研究细胞间相互作用的革命性途径。
Cancers (Basel). 2021 Feb 23;13(4):930. doi: 10.3390/cancers13040930.
10
Mouse Models of Peritoneal Carcinomatosis to Develop Clinical Applications.用于临床应用开发的腹膜癌病小鼠模型。
Cancers (Basel). 2021 Feb 25;13(5):963. doi: 10.3390/cancers13050963.
剖析转移性乳腺癌循环肿瘤细胞的异质性:远不止大海捞针那么简单。
Int J Mol Sci. 2016 Oct 24;17(10):1775. doi: 10.3390/ijms17101775.
4
Label-free enumeration, collection and downstream cytological and cytogenetic analysis of circulating tumor cells.循环肿瘤细胞的无标记计数、收集及下游细胞学和细胞遗传学分析
Sci Rep. 2016 Oct 14;6:35474. doi: 10.1038/srep35474.
5
Circulating miR-21 as an independent predictive biomarker for chemoresistance in esophageal squamous cell carcinoma.循环miR-21作为食管鳞状细胞癌化疗耐药的独立预测生物标志物。
Am J Cancer Res. 2016 Jul 1;6(7):1511-23. eCollection 2016.
6
Affinity Versus Label-Free Isolation of Circulating Tumor Cells: Who Wins?亲和与无标记法分离循环肿瘤细胞:谁更胜一筹?
Small. 2016 Sep;12(33):4450-63. doi: 10.1002/smll.201601394. Epub 2016 Jul 20.
7
Association of AR-V7 on Circulating Tumor Cells as a Treatment-Specific Biomarker With Outcomes and Survival in Castration-Resistant Prostate Cancer.循环肿瘤细胞上的AR-V7作为去势抵抗性前列腺癌治疗特异性生物标志物与治疗结果及生存的相关性
JAMA Oncol. 2016 Nov 1;2(11):1441-1449. doi: 10.1001/jamaoncol.2016.1828.
8
A Method for Detecting Circulating Tumor Cells Based on the Measurement of Single-Cell Metabolism in Droplet-Based Microfluidics.基于液滴微流控中单细胞代谢测量的循环肿瘤细胞检测方法。
Angew Chem Int Ed Engl. 2016 Jul 18;55(30):8581-4. doi: 10.1002/anie.201602328. Epub 2016 Jun 1.
9
Engineering a 3D microfluidic culture platform for tumor-treating field application.工程化 3D 微流控培养平台用于肿瘤电场治疗。
Sci Rep. 2016 May 24;6:26584. doi: 10.1038/srep26584.
10
KRAS-MEK Signaling Controls Ago2 Sorting into Exosomes.KRAS-丝裂原活化蛋白激酶信号通路控制AGO2分选进入外泌体。
Cell Rep. 2016 May 3;15(5):978-987. doi: 10.1016/j.celrep.2016.03.085. Epub 2016 Apr 21.